Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Development
2009 Jul 01;13613:2277-86. doi: 10.1242/dev.032227.
Show Gene links
Show Anatomy links
MBD4 and MLH1 are required for apoptotic induction in xDNMT1-depleted embryos.
Ruzov A, Shorning B, Mortusewicz O, Dunican DS, Leonhardt H, Meehan RR.
???displayArticle.abstract???
Loss of the of the maintenance methyltransferase xDNMT1 during Xenopus development results in premature transcription and activation of a p53-dependent apoptotic program that accounts for embryo lethality. Here, we show that activation of the apoptotic response is signalled through the methyl-CpG binding protein xMBD4 and the mismatch repair pathway protein xMLH1. Depletion of xMBD4 or xMLH1 increases the survival rate of xDNMT1-depleted embryos, whereas overexpression of these proteins in embryos induces programmed cell death at the onset of gastrulation. MBD4 interacts directly with both DNMT1 and MLH1, leading to recruitment of the latter to heterochromatic sites that are coincident with DNMT1 localisation. Time-lapse microscopy of micro-irradiated mammalian cells shows that MLH1/MBD4 (like DNMT1) can accumulate at DNA damage sites. We propose that xMBD4/xMLH1 participates in a novel G2 checkpoint that is responsive to xDNMT1p levels in developing embryos and cells.
Agoston,
Increased protein stability causes DNA methyltransferase 1 dysregulation in breast cancer.
2005, Pubmed
Agoston,
Increased protein stability causes DNA methyltransferase 1 dysregulation in breast cancer.
2005,
Pubmed Bartek,
Chk1 and Chk2 kinases in checkpoint control and cancer.
2003,
Pubmed Bartkova,
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis.
2005,
Pubmed Bellacosa,
MED1, a novel human methyl-CpG-binding endonuclease, interacts with DNA mismatch repair protein MLH1.
1999,
Pubmed Bellacosa,
Functional interactions and signaling properties of mammalian DNA mismatch repair proteins.
2001,
Pubmed Biniszkiewicz,
Dnmt1 overexpression causes genomic hypermethylation, loss of imprinting, and embryonic lethality.
2002,
Pubmed Bodmer,
Cancer genetics: colorectal cancer as a model.
2006,
Pubmed Brown,
The mismatch repair system is required for S-phase checkpoint activation.
2003,
Pubmed Brown,
DNMT1 knockout delivers a strong blow to genome stability and cell viability.
2007,
Pubmed Canman,
Activation of the ATM kinase by ionizing radiation and phosphorylation of p53.
1998,
Pubmed Cazalla,
A rapid and efficient protocol to purify biologically active recombinant proteins from mammalian cells.
2005,
Pubmed Chen,
Proteolysis of the mismatch repair protein MLH1 by caspase-3 promotes DNA damage-induced apoptosis.
2004,
Pubmed Chen,
Complete inactivation of DNMT1 leads to mitotic catastrophe in human cancer cells.
2007,
Pubmed Cordenonsi,
Links between tumor suppressors: p53 is required for TGF-beta gene responses by cooperating with Smads.
2003,
Pubmed
,
Xenbase Cortellino,
The base excision repair enzyme MED1 mediates DNA damage response to antitumor drugs and is associated with mismatch repair system integrity.
2003,
Pubmed De Marzo,
Abnormal regulation of DNA methyltransferase expression during colorectal carcinogenesis.
1999,
Pubmed Dunican,
xDnmt1 regulates transcriptional silencing in pre-MBT Xenopus embryos independently of its catalytic function.
2008,
Pubmed
,
Xenbase Easwaran,
Replication-independent chromatin loading of Dnmt1 during G2 and M phases.
2004,
Pubmed Gius,
Distinct effects on gene expression of chemical and genetic manipulation of the cancer epigenome revealed by a multimodality approach.
2004,
Pubmed Goll,
Eukaryotic cytosine methyltransferases.
2005,
Pubmed Guo,
Mismatch repair genes identified using genetic screens in Blm-deficient embryonic stem cells.
2004,
Pubmed Halazonetis,
An oncogene-induced DNA damage model for cancer development.
2008,
Pubmed Hendrich,
The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites.
1999,
Pubmed Hendrich,
Identification and characterization of a family of mammalian methyl-CpG binding proteins.
1998,
Pubmed Hensey,
A developmental timer that regulates apoptosis at the onset of gastrulation.
1997,
Pubmed
,
Xenbase Hershko,
Methylation of HoxA5 and HoxB5 and its relevance to expression during mouse development.
2003,
Pubmed Jackson-Grusby,
Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation.
2001,
Pubmed Jair,
De novo CpG island methylation in human cancer cells.
2006,
Pubmed Jeffery,
Components of the DNA methylation system of chromatin control are RNA-binding proteins.
2004,
Pubmed Kimura,
Methyl-CpG-binding protein, MeCP2, is a target molecule for maintenance DNA methyltransferase, Dnmt1.
2003,
Pubmed Klose,
Genomic DNA methylation: the mark and its mediators.
2006,
Pubmed Kondo,
The thymine DNA glycosylase MBD4 represses transcription and is associated with methylated p16(INK4a) and hMLH1 genes.
2005,
Pubmed Lande-Diner,
Role of DNA methylation in stable gene repression.
2007,
Pubmed Lei,
De novo DNA cytosine methyltransferase activities in mouse embryonic stem cells.
1996,
Pubmed Leonhardt,
A targeting sequence directs DNA methyltransferase to sites of DNA replication in mammalian nuclei.
1992,
Pubmed Levine,
The P53 pathway: what questions remain to be explored?
2006,
Pubmed Li,
Targeted mutation of the DNA methyltransferase gene results in embryonic lethality.
1992,
Pubmed Luo,
ATM-mediated stabilization of hMutL DNA mismatch repair proteins augments p53 activation during DNA damage.
2004,
Pubmed Meehan,
DNA methylation and control of gene expression in vertebrate development.
2001,
Pubmed
,
Xenbase Meehan,
Epigenetic silencing in embryogenesis.
2005,
Pubmed Miquel,
Frequent alteration of DNA damage signalling and repair pathways in human colorectal cancers with microsatellite instability.
2007,
Pubmed Morgan,
Epigenetic reprogramming in mammals.
2005,
Pubmed Mortusewicz,
Recruitment of DNA methyltransferase I to DNA repair sites.
2005,
Pubmed Mortusewicz,
Feedback-regulated poly(ADP-ribosyl)ation by PARP-1 is required for rapid response to DNA damage in living cells.
2007,
Pubmed Palii,
DNA methylation inhibitor 5-Aza-2'-deoxycytidine induces reversible genome-wide DNA damage that is distinctly influenced by DNA methyltransferases 1 and 3B.
2008,
Pubmed Papadopoulos,
Mutation of a mutL homolog in hereditary colon cancer.
1994,
Pubmed Parsons,
MED1: a central molecule for maintenance of genome integrity and response to DNA damage.
2003,
Pubmed Rai,
DNA demethylation in zebrafish involves the coupling of a deaminase, a glycosylase, and gadd45.
2008,
Pubmed Ruzov,
Kaiso is a genome-wide repressor of transcription that is essential for amphibian development.
2004,
Pubmed
,
Xenbase Saito,
Increased protein expression of DNA methyltransferase (DNMT) 1 is significantly correlated with the malignant potential and poor prognosis of human hepatocellular carcinomas.
2003,
Pubmed Sansom,
MBD4 deficiency reduces the apoptotic response to DNA-damaging agents in the murine small intestine.
2003,
Pubmed Schroering,
The cell cycle and DNA mismatch repair.
2007,
Pubmed Shiloh,
ATM and related protein kinases: safeguarding genome integrity.
2003,
Pubmed Stancheva,
Loss of the maintenance methyltransferase, xDnmt1, induces apoptosis in Xenopus embryos.
2001,
Pubmed
,
Xenbase Stancheva,
Transient depletion of xDnmt1 leads to premature gene activation in Xenopus embryos.
2000,
Pubmed
,
Xenbase Takebayashi,
Major and essential role for the DNA methylation mark in mouse embryogenesis and stable association of DNMT1 with newly replicated regions.
2007,
Pubmed Takebayashi-Suzuki,
Interplay between the tumor suppressor p53 and TGF beta signaling shapes embryonic body axes in Xenopus.
2003,
Pubmed
,
Xenbase Vertino,
DNMT1 is a component of a multiprotein DNA replication complex.
2002,
Pubmed Zhang,
Apoptosis induced by overexpression of hMSH2 or hMLH1.
1999,
Pubmed
